Penserra Capital Management LLC Relay Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$26.0 - $37.03 $54,990 - $78,318	-2,115 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $297 - $379	10 Added 0.48%	2,115 $66,000
Q2 2021 Aug 12, 2021	BUY	$27.5 - $38.19 $1,925 - $2,673	70 Added 3.44%	2,105 $77,000
Q1 2021 May 13, 2021	SELL	$32.52 - $61.53 $975 - $1,845	-30 Reduced 1.45%	2,035 $70,000
Q4 2020 Feb 12, 2021	BUY	$35.51 - $54.03 $73,328 - $111,571	2,065 New	2,065 $85,000

204

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $536M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.